Nicolas Berg, Redalpine Venture Partners, Journalist BR
Nicolas Berg, Redalpine Venture Partners, Journalist BR
Contact:
Oliver Rinner, co-founder and CSO
Phone:
E-Mail: rinner@biognosys.ch
KEYWORDS:

[ Download Photos ]

attachments to announcement
Biognosys Brings Proteomic Breakthroughs to Mainstream Users
back to announcement
photos
Oliver Rinner, Proteomics Pioneer
[ download press photo ]
title: Oliver Rinner, Proteomics Pioneer
image text: Dr. Oliver Rinner, Biognosys' Head of research, has developed mass spectrometry software published in Nature Biotech and Nature Methods. For Biognosys he has set up a proprietary pipeline for high throughput assay design and MRM analysis.
copyright: Redalpine Venture Partners AG
Ruedi Aebersold, Proteomics Pioneer
[ download press photo ]
title: Ruedi Aebersold, Proteomics Pioneer
image text: Prof. Ruedi Aebersold, Institute of Molecular Systems Biology, ETH Zurich, is one of the pioneers in the field of proteomics. He is known for developing a series of methods that have found wide application in analytical protein chemistry and proteomics like a new class of reagents termed Isotope Coded Affinity Tag (ICAT) reagents used in quantitative mass spectrometry.
copyright: Redalpine Venture Partners AG
From target protein to assay within week
[ download press photo ]
title: From target protein to assay within week
image text: Imagine having a protein assay designed for almost every protein you want within weeks. And imagine being able to apply 100 different tests in a single experiment. This is what MRM can do - not with antibodies but with a triple quadrupole mass spectrometer that serves as universal platform, while the specificity comes with carefully designed MRM assays. MRM Assays define the necessary coordinates to target a specific protein using a triple Quadrupole mass spectrometer. An optimal assay therefore should define: * Which peptide of a target protein should be selected? * At which elution time during the chromatography is the peptide expected? * Which are the best fragments that should be monitored in the target matrix? Biognosys has exclusively licensed a method for efficient design of MRM assays from any organism based on synthetic proteomes. We offer these assays for direct plug-in into customer machines or we develop assays as contract research, including full measurement service.
copyright: Redalpine Venture Partners AG